Neurological toxicity due to antimonial treatment for refractory visceral leishmaniasis

Neurological toxicity due to antimonial treatment for refractory visceral leishmaniasis

Introduction: Although pentavalent antimonials are no longer considered the first-line therapy for visceral leishmaniasis in the developed world, they are still used in certain geographical areas and in refractory cases. These drugs have a great number of adverse effects; however, neurological toxic...

Full description

Bibliographic Details
Main Authors: Marta Maristany Bosch, Guillermo Cuervo, Elisabeth Matas Martín, Misericordia Veciana de las Heras, Jordi Pedro Pérez, Sergio Martínez Yélamos, Nuria Sabé Fernández
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Clinical Neurophysiology Practice
Subjects:
Antimonials
Neurotoxicity
Sodium stibogluconate
Meglumine antimoniate
Myoclonus
Beta activity
Online Access:http://www.sciencedirect.com/science/article/pii/S2467981X21000214

Internet

http://www.sciencedirect.com/science/article/pii/S2467981X21000214

Similar Items